Literature DB >> 1980024

[Treatment of Wolff-Parkinson-White syndrome associated with asthma].

H Otake1, G Watanabe, A Mukai, M Tubota, T Misaki, T Iwa, S Ozawa.   

Abstract

We performed division of accessory pathways in five asthma patients associated with Wolff-Parkinson-White (WPW) syndrome, for whom the administration of a beta-blocker for the tachycardia is contraindicated, and the administration of bronchodilators for the asthma attack may cause premature ventricular contractions. As a result, the tachycardic attacks disappeared postoperatively, both at rest and following administration of bronchodilators. Radical treatment of WPW syndrome by division the accessory pathway is considered to be necessary for the safe treatment of asthma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980024

Source DB:  PubMed          Journal:  Kokyu To Junkan        ISSN: 0452-3458


  1 in total

1.  Impact of theophylline use in Wolff-Parkinson-White syndrome.

Authors:  J Agwunobi; M Abedin; M Young; M Beeram; S Sinkford
Journal:  J Natl Med Assoc       Date:  1996-07       Impact factor: 1.798

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.